Private Equity

News

Trive Capital nears sale of Valor Healthcare, sources say

Valor Healthcare could command a valuation based on $35m EBITDA generated over the last year, said three sources.

2 min read · 16 November 2026

Serent Capital completes majority investment in pool service software provider Pool Brain

The company’s software helps US pool service businesses quote jobs, plan routes, bill customers and automate chemical dosing.

2 min read · 18 November 2026

Carlyle, KKR commit around $475m to music royalty platform Litmus Music

The Los Angeles and New York-based business, founded in 2022, has around $1.4 billion in assets under management across more than 100,000 copyrights and recordings.

2 min read · 18 November 2026

Bluestone Equity backs fragmented live event design market with 11th St Workshop

11th St Workshop, a live event design, fabrication and installation business, is Bluestone's first buyout.

2 min read · 18 November 2026

Riverside strikes deal to sell Smartways to UPS in healthcare logistics exit

Smartways transports time-critical medical technologies and life sciences products to hospitals and other healthcare providers across Australia and New Zealand.

2 min read · 18 November 2026

Eurazeo seals Aroma-Zone sale to Partners Group, reinvests €228m

Aroma-Zone is a natural beauty, wellness and self-care brand founded by the Vausselin family in 1999.

1 min read · 18 November 2026

Sixth Street takes $350m minority stake in Stride-backed snack brand Chomps

Co-founded 14 years ago by CEO Rashid Ali and chairman Pete Maldonado, Chomps makes meat snacks.

2 min read · 17 November 2026

EQT agrees to acquire Flatiron Energy from Hull Street Energy

The battery storage developer has grown its portfolio nearly tenfold to 24 GWh since 2022 and has 2 GWh under construction.

2 min read · 17 November 2026

Claritas Capital, TruArc Partners strike HCTec exit to Recruit, Mitsui-owned CSI

The Nashville-based company provides healthcare IT managed services to more than 250 health systems across the US.

1 min read · 17 November 2026

Apollo, OrbiMed-backed vVARDIS prices NYSE IPO at $18 per share

The Swiss dental med-tech company sells non-invasive products to dental professionals under its Curodont brand.

1 min read · 17 November 2026

Inflexion’s Rosemont Pharmaceuticals agrees deal for Aytu BioPharma at 41.1 percent premium

Aytu is a US specialty pharmaceutical company focused on central nervous system diseases, with an ADHD portfolio and a depression treatment.

2 min read · 17 November 2026

Showing 1 to 10 of 120,611 results